Mirum Pharmaceuticals, Inc.
MIRM · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $521M | $337M | +54.7% |
| Operating income | −$22.1M | −$87.6M | +74.7% |
| Net income | −$23.4M | −$87.9M | +73.4% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 3, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $186M | $133M | +39.6% |
| Operating income | −$59.7M | $2.60M | |
| Net income | −$40.8M | $2.90M |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Mirum Pharmaceuticals's revenue in FY2025?
- $521M in FY2025 (Fiscal year ended Dec 31, 2025), +54.7% vs $337M a year earlier, per its 10-K filed Feb 2026.
- Was Mirum Pharmaceuticals profitable in FY2025?
- No: net income was −$23.4M and operating income −$22.1M in FY2025.
- What was Mirum Pharmaceuticals's revenue in Q3 2026?
- $186M (+39.6% vs a year earlier), per its Form 10-Q filed Nov 3, 2026.